ARCHIVES

Brawley: CMS Got it Right in Lung Cancer Screening Decision

This article is from The Cancer Letter archive.

Vol. 40 No. 43 | November 14, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group Clinical Trials Approved

February 26, 2010

Mayer Will Emphasize Rehab Research While Serving On NCAB

May 24, 1991

NIH Consensus Conference Concludes That MRI In “Unusually Rewarding,” Calls For More Studies

November 6, 1987

FDA: Silicone Breast Implants Safe, But Not “Lifetime Device”

June 24, 2011

How a two-faced media covered cancer: Promoting research—and cigarettes

April 29, 2022

FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March.

January 21, 2005